Selective anticancer agents suppress aging in Drosophila

Oncotarget

Volumn 4, Issue 9, 2013, Pages 1507-1526

  Danilov, Anton ^a   Shaposhnikov, Mikhail ^a,b   Plyusnina, Ekaterina ^a,b   Kogan, Valeria ^c,d   Fedichev, Peter ^c,d   Moskalev, Alexey ^a,b,c  

^a INSTITUTE OF BIOLOGY   (Russian Federation)

^b SYKTYVKAR STATE UNIVERSITY   (Russian Federation)

^c MOSCOW INSTITUTE OF PHYSICS AND TECHNOLOGY   (Russian Federation)

^d Quantum Pharmaceuticals   (Russian Federation)

Author keywords

Aging suppressive substances; Anticancer agents; Drosophila melanogaster; iNOS; Longevity; NF B; PI3K; Quality of life; TOR

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N4 [2 (4 PHENOXYPHENYL)ETHYL] 4,6 QUINAZOLINEDIAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PYRROLIDINE DITHIOCARBAMATE; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE; UNCLASSIFIED DRUG; WORTMANNIN;

AGING; ANIMAL EXPERIMENT; ARTICLE; BIOINFORMATICS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; DRUG EFFECT; DRUG MECHANISM; FEMALE; FEMALE FERTILITY; LIFESPAN; LOCOMOTION; MALE; NONHUMAN; QUALITY OF LIFE; SEX DIFFERENCE;

AGING; ANIMALS; ANTINEOPLASTIC AGENTS; DROSOPHILA MELANOGASTER; FEMALE; MALE; MUTATION; SEX FACTORS; SIROLIMUS;

EID: 84884677201     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1272     Document Type: Article

References (124)

1. Tacutu R, Craig T, Budovsky A, Wuttke D, Lehmann G, Taranukha D, Costa J, Fraifeld VE and de Magalhães JP. Human Ageing Genomic Resources: integrated databases and tools for the biology and genetics of ageing. Nucleic Acids Res. 2013; 41(Database issue):D1027-1033.
2. Kaeberlein M and Kennedy BK. Large-scale identification in yeast of conserved ageing genes. Mech Ageing Dev. 2005; 126(1):17-21.
3. Kapahi P and Zid B. TOR pathway: linking nutrient sensing to life span. Sci Aging Knowledge Environ. 2004; 2004(36):PE34.
4. Vellai T, Takacs-Vellai K, Zhang Y, Kovacs AL, Orosz L and Muller F. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature. 2003; 426(6967):620.
5. Friedman DB and Johnson TE. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics. 1988; 118(1):75-86.
6. Helenius M, Hanninen M, Lehtinen SK and Salminen A. Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-κB. Biochem J. 1996; 318 ( Pt 2):603-608.
7. Kriete A and Mayo KL. Atypical pathways of NF-κB activation and aging. Exp Gerontol. 2009; 44(4):250-255.
8. Siles E, Martinez-Lara E, Canuelo A, Sanchez M, Hernandez R, Lopez-Ramos JC, Del Moral ML, Esteban FJ, Blanco S, Pedrosa JA, Rodrigo J and Peinado MA. Age-related changes of the nitric oxide system in the rat brain. Brain Res. 2002; 956(2):385-392.
9. Vernet D, Bonavera JJ, Swerdloff RS, Gonzalez-Cadavid NF and Wang C. Spontaneous expression of inducible nitric oxide synthase in the hypothalamus and other brain regions of aging rats. Endocrinology. 1998; 139(7):3254-3261.
10. Powers RW, 3rd, Kaeberlein M, Caldwell SD, Kennedy BK and Fields S. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 2006; 20(2):174-184.
11. Bjedov I, Toivonen JM, Kerr F, Slack C, Jacobson J, Foley A and Partridge L. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. 2010; 11(1):35-46.
12. Moskalev AA and Shaposhnikov MV. Pharmacological inhibition of phosphoinositide 3 and TOR kinases improves survival of Drosophila melanogaster. Rejuvenation Res. 2010; 13(2-3):246-247.
13. Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, Yurova MN, Antoch MP and Blagosklonny MV. Rapamycin extends maximal lifespan in cancer-prone mice. The American journal of pathology. 2010; 176(5):2092-2097.
14. Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, Yurova MN, Rosenfeld SV and Blagosklonny MV. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle. 2011; 10(24):4230-4236.
15. Comas M, Toshkov I, Kuropatwinski KK, Chernova OB, Polinsky A, Blagosklonny MV, Gudkov AV and Antoch MP. New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53-/- mice by delaying carcinogenesis. Aging (Albany NY). 2012; 4(10):715-722.
16. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E and Miller RA. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009; 460(7253):392-395.
17. Komarova EA, Antoch MP, Novototskaya LR, Chernova OB, Paszkiewicz G, Leontieva OV, Blagosklonny MV and Gudkov AV. Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/- mice. Aging (Albany NY). 2012; 4(10):709-714.
18. Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2011; 66(2):191-201.
19. Wilkinson JE, Burmeister L, Brooks SV, Chan CC, Friedline S, Harrison DE, Hejtmancik JF, Nadon N, Strong R, Wood LK, Woodward MA and Miller RA. Rapamycin slows aging in mice. Aging Cell. 2012; 11(4):675-682.
20. Babar P, Adamson C, Walker GA, Walker DW and Lithgow GJ. P13-kinase inhibition induces dauer formation, thermotolerance and longevity in C. elegans. Neurobiol Aging. 1999; 20(5):513-519.
21. Moskalev AA and Shaposhnikov MV. [Longevity extension by specific inhibition of pI3K in Drosophila melanogaster]. Adv Gerontol. 2008; 21(4):602-606.
22. Moskalev A and Shaposhnikov M. Pharmacological inhibition of NF-κB prolongs lifespan of Drosophila melanogaster. Aging (Albany NY). 2011; 3(4):391-394.
23. de la Lastra CA and Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res. 2005; 49(5):405-430.
24. Burger JM and Promislow DE. Sex-specific effects of interventions that extend fly life span. Sci Aging Knowl Environ. 2004; 2004(28):pe30.
25. Chang TKH, Waxman DJ and Lyubimov AV. (2011). Sex Differences in Drug Metabolism. Encyclopedia of Drug Metabolism and Interactions: John Wiley & Sons, Inc.).
26. Blagosklonny MV. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition. Cell Cycle. 2006; 5(18):2087-2102.
27. Zhang G, Li J, Purkayastha S, Tang Y, Zhang H, Yin Y, Li B, Liu G and Cai D. Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH. Nature. 2013; 497(7448):211-216.
28. Lewinska A, Macierzynska E, Grzelak A and Bartosz G. A genetic analysis of nitric oxide-mediated signaling during chronological aging in the yeast. Biogerontology. 2011; 12(4):309-320.
29. Montesanto A, Crocco P, Tallaro F, Pisani F, Mazzei B, Mari V, Corsonello A, Lattanzio F, Passarino G and Rose G. Common polymorphisms in nitric oxide synthase (NOS) genes influence quality of aging and longevity in humans. Biogerontology. 2013; 14(2):177-186.
30. Fasolo A and Sessa C. mTOR inhibitors in the treatment of cancer. Expert opinion on investigational drugs. 2008; 17(11):1717-1734.
31. Morgensztern D and McLeod HL. PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer Drugs. 2005; 16(8):797-803.
32. McCubrey JA, Steelman LS, Chappell WH, Sun L, Davis NM, Abrams SL, Franklin RA, Cocco L, Evangelisti C, Chiarini F, Martelli AM, Libra M, Candido S, Ligresti G, Malaponte G, Mazzarino MC, et al. Advances in targeting signal transduction pathways. Oncotarget. 2012; 3(12):1505-1521.
33. Garrett JT, Chakrabarty A and Arteaga CL. Will PI3K pathway inhibitors be effective as single agents in patients with cancer? Oncotarget. 2011; 2(12):1314-1321.
34. Kim HJ, Hawke N and Baldwin AS. NF-κB and IKK as therapeutic targets in cancer. Cell Death Differ. 2006; 13(5):738-747.
35. Janakiram NB and Rao CV. iNOS-selective inhibitors for cancer prevention: promise and progress. Future medicinal chemistry. 2012; 4(17):2193-2204.
36. Gems D and Partridge L. Genetics of longevity in model organisms: debates and paradigm shifts. Annu Rev Physiol. 2013; 75:621-644.
37. Gorbunova V, Hine C, Tian X, Ablaeva J, Gudkov AV, Nevo E and Seluanov A. Cancer resistance in the blind mole rat is mediated by concerted necrotic cell death mechanism. Proc Natl Acad Sci USA. 2012; 109(47):19392-19396.
38. Seluanov A, Hine C, Azpurua J, Feigenson M, Bozzella M, Mao Z, Catania KC and Gorbunova V. Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat. Proc Natl Acad Sci USA. 2009; 106(46):19352-19357.
39. Seluanov A, Hine C, Bozzella M, Hall A, Sasahara TH, Ribeiro AA, Catania KC, Presgraves DC and Gorbunova V. Distinct tumor suppressor mechanisms evolve in rodent species that differ in size and lifespan. Aging Cell. 2008; 7(6):813-823.
40. Tian X, Azpurua J, Hine C, Vaidya A, Myakishev-Rempel M, Ablaeva J, Mao Z, Nevo E, Gorbunova V and Seluanov A. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature. 2013.
41. Seim I, Fang X, Xiong Z, Lobanov AV, Huang Z, Ma S, Feng Y, Turanov AA, Zhu Y, Lenz TL, Gerashchenko MV, Fan D, Yim SH, Yao X, Jordan D, Xiong Y, et al. Genome analysis reveals insights into physiology and longevity of the Brandt's bat Myotis brandtii. Nature Communications. in press.
42. Budovsky A, Tacutu R, Yanai H, Abramovich A, Wolfson M and Fraifeld V. Common gene signature of cancer and longevity. Mech Ageing Dev. 2009; 130(1-2):33-39.
43. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH and Burgering BM. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature. 2002; 419(6904):316-321.
44. Rouault JP, Kuwabara PE, Sinilnikova OM, Duret L, Thierry-Mieg D and Billaud M. Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN. Curr Biol. 1999; 9(6):329-332.
45. Feng Z, Lin M and Wu R. The Regulation of Aging and Longevity: A New and Complex Role of p53. Genes Cancer. 2011; 2(4):443-452.
46. Aoki M, Blazek E and Vogt PK. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proc Natl Acad Sci USA. 2001; 98(1):136-141.
47. Chang HW, Aoki M, Fruman D, Auger KR, Bellacosa A, Tsichlis PN, Cantley LC, Roberts TM and Vogt PK. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science. 1997; 276(5320):1848-1850.
48. López-Otín C, Blasco MA, Partridge L, Serrano M and Kroemer G. The Hallmarks of Aging. Cell. 2013; 153(6):1194-1217.
49. Jafari M. Drosophila melanogaster as a model system for the evaluation of anti-aging compounds. Fly (Austin). 2010; 4(3).
50. Lucanic M, Lithgow GJ and Alavez S. Pharmacological lifespan extension of invertebrates. Ageing Res Rev. 2013; 12(1):445-458.
51. Spindler SR, Li R, Dhahbi JM, Yamakawa A and Sauer F. Novel protein kinase signaling systems regulating lifespan identified by small molecule library screening using Drosophila. PLoS ONE. 2012; 7(2):e29782.
52. Ayyadevara S, Alla R, Thaden JJ and Shmookler Reis RJ. Remarkable longevity and stress resistance of nematode PI3K-null mutants. Aging Cell. 2008; 7(1):13-22.
53. Oldham S, Montagne J, Radimerski T, Thomas G and Hafen E. Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. Genes Dev. 2000; 14(21):2689-2694.
54. MacDougall LK, Domin J and Waterfield MD. A family of phosphoinositide 3-kinases in Drosophila identifies a new mediator of signal transduction. Curr Biol. 1995; 5(12):1404-1415.
55. Dushay MS, Asling B and Hultmark D. Origins of immunity: Relish, a compound Rel-like gene in the antibacterial defense of Drosophila. Proc Natl Acad Sci USA. 1996; 93(19):10343-10347.
56. Norris JL and Manley JL. Selective nuclear transport of the Drosophila morphogen dorsal can be established by a signaling pathway involving the transmembrane protein Toll and protein kinase A. Genes Dev. 1992; 6(9):1654-1667.
57. Stasiv Y, Regulski M, Kuzin B, Tully T and Enikolopov G. The Drosophila nitric-oxide synthase gene (dNOS) encodes a family of proteins that can modulate NOS activity by acting as dominant negative regulators. J Biol Chem. 2001; 276(45):42241-42251.
58. Alvers AL, Wood MS, Hu D, Kaywell AC, Dunn WA, Jr. and Aris JP. Autophagy is required for extension of yeast chronological life span by rapamycin. Autophagy. 2009; 5(6):847-849.
59. Norman BH, Shih C, Toth JE, Ray JE, Dodge JA, Johnson DW, Rutherford PG, Schultz RM, Worzalla JF and Vlahos CJ. Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs. J Med Chem. 1996; 39(5):1106-1111.
60. Shaposhnikov MV, Danilov AA and Moskalev AA. [Pharmacological PI 3-kinase inhibitors induce radioprotective effect in Drosophila melanogaster imago]. Radiatsionnaia biologiia, radioecologiia / Rossiiskaia akademiia nauk. 2010; 50(6):649-655.
61. Yoshinaga T, Kaneko G, Kinoshita S, Furukawa S, Tsukamoto K and Watabe S. (2005). Insulin-like growth factor signaling pathway involved in regulating longevity of rotifers. Rotifera X, pp. 347-352.
62. Broughton SJ, Piper MD, Ikeya T, Bass TM, Jacobson J, Driege Y, Martinez P, Hafen E, Withers DJ, Leevers SJ and Partridge L. Longer lifespan, altered metabolism, and stress resistance in Drosophila from ablation of cells making insulin-like ligands. Proc Natl Acad Sci USA. 2005; 102(8):3105-3110.
63. Liu SF, Ye X and Malik AB. Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes. Circulation. 1999; 100(12):1330-1337.
64. Schreck R, Meier B, Mannel DN, Droge W and Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med. 1992; 175(5):1181-1194.
65. Tobe M, Isobe Y, Tomizawa H, Nagasaki T, Takahashi H, Fukazawa T and Hayashi H. Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation. Bioorg Med Chem. 2003; 11(3):383-391.
66. Donato AJ, Black AD, Jablonski KL, Gano LB and Seals DR. Aging is associated with greater nuclear NFκB, reduced IκBα, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans. Aging Cell. 2008; 7(6):805-812.
67. Wiggins JE, Patel SR, Shedden KA, Goyal M, Wharram BL, Martini S, Kretzler M and Wiggins RC. NFκB promotes inflammation, coagulation, and fibrosis in the aging glomerulus. J Am Soc Nephrol. 2010; 21(4):587-597.
68. Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJ, Kardakaris R, Polykratis A, Kollias G, de Winther MP and Pasparakis M. Endothelial cell-specific NF-κB inhibition protects mice from atherosclerosis. Cell Metab. 2008; 8(5):372-383.
69. Adler AS, Kawahara TL, Segal E and Chang HY. Reversal of aging by NFκB blockade. Cell Cycle. 2008; 7(5):556-559.
70. Adler AS, Sinha S, Kawahara TL, Zhang JY, Segal E and Chang HY. Motif module map reveals enforcement of aging by continual NF-κB activity. Genes Dev. 2007; 21(24):3244-3257.
71. Libert S. Insights into physiology of aging and novel ways to increase lifespan. Fly. 2007; 1(2):113-115.
72. Kawahara TL, Michishita E, Adler AS, Damian M, Berber E, Lin M, McCord RA, Ongaigui KC, Boxer LD, Chang HY and Chua KF. SIRT6 links histone H3 lysine 9 deacetylation to NF-κB-dependent gene expression and organismal life span. Cell. 2009; 136(1):62-74.
73. Tilstra JS, Robinson AR, Wang J, Gregg SQ, Clauson CL, Reay DP, Nasto LA, St Croix CM, Usas A, Vo N, Huard J, Clemens PR, Stolz DB, Guttridge DC, Watkins SC, Garinis GA, et al. NF-κB inhibition delays DNA damage-induced senescence and aging in mice. J Clin Invest. 2012; 122(7):2601-2612.
74. Cao Y, Chtarbanova S, Petersen AJ and Ganetzky B. Dnr1 mutations cause neurodegeneration in Drosophila by activating the innate immune response in the brain. Proc Natl Acad Sci USA. 2013; 110(19):E1752-1760.
75. Tsutsui M, Shimokawa H, Otsuji Y, Ueta Y, Sasaguri Y and Yanagihara N. Nitric oxide synthases and cardiovascular diseases: insights from genetically modified mice. Circulation journal: official journal of the Japanese Circulation Society. 2009; 73(6):986-993.
76. Tian J, Yan Z, Wu Y, Zhang SL, Wang K, Ma XR, Guo L, Wang J, Zuo L, Liu JY, Quan L and Liu HR. Inhibition of iNOS protects endothelial-dependent vasodilation in aged rats. Acta pharmacologica Sinica. 2010; 31(10):1324-1328.
77. Wong R, Piper MD, Wertheim B and Partridge L. Quantification of food intake in Drosophila. PLoS ONE. 2009; 4(6):e6063.
78. Foster MW, Hess DT and Stamler JS. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med. 2009; 15(9):391-404.
79. Ropelle ER, Pauli JR, Cintra DE, da Silva AS, De Souza CT, Guadagnini D, Carvalho BM, Caricilli AM, Katashima CK, Carvalho-Filho MA, Hirabara S, Curi R, Velloso LA, Saad MJ and Carvalheira JB. Targeted disruption of inducible nitric oxide synthase protects against aging, S-nitrosation, and insulin resistance in muscle of male mice. Diabetes. 2013; 62(2):466-470.
80. Tang CH, Wei W and Liu L. Regulation of DNA repair by S-nitrosylation. Biochim Biophys Acta. 2012; 1820(6):730-735.
81. Moskalev AA, Shaposhnikov MV, Plyusnina EN, Zhavoronkov A, Budovsky A, Yanai H and Fraifeld VE. The role of DNA damage and repair in aging through the prism of Koch-like criteria. Ageing Res Rev. 2013; 12(2):661-684.
82. Weber AL, Khan GF, Magwire MM, Tabor CL, Mackay TFC and Anholt RRH. Genome-Wide Association Analysis of Oxidative Stress Resistance in Drosophila melanogaster. PLoS ONE. 2012; 7(4):e34745.
83. Bonduriansky R, Maklakov A, Zajitschek F and Brooks R. Sexual selection, sexual conflict and the evolution of ageing and life span. Funct Ecol. 2008; 22(3):443-453.
84. Alavez S, Vantipalli MC, Zucker DJ, Klang IM and Lithgow GJ. Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan. Nature. 2011; 472(7342):226-229.
85. Okuyama T, Inoue H, Ookuma S, Satoh T, Kano K, Honjoh S, Hisamoto N, Matsumoto K and Nishida E. The ERK-MAPK pathway regulates longevity through SKN-1 and insulin-like signaling in Caenorhabditis elegans. J Biol Chem. 2010; 285(39):30274-30281.
86. Wanke V, Cameroni E, Uotila A, Piccolis M, Urban J, Loewith R and De Virgilio C. Caffeine extends yeast lifespan by targeting TORC1. Mol Microbiol. 2008; 69(1):277-285.
87. Dhillon AS, Hagan S, Rath O and Kolch W. MAP kinase signalling pathways in cancer. Oncogene. 2007; 26(22):3279-3290.
88. Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer. 2009; 9(8):550-562.
89. Vinogradova IA, Anisimov VN, Bukalev AV, Semenchenko AV and Zabezhinski MA. Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in rats. AGING. 2009; 1(10):855-865.
90. Cai J, Zhang N, Zheng Y, de Wilde RF, Maitra A and Pan D. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 2010; 24(21):2383-2388.
91. Carlson ME, Silva HS and Conboy IM. Aging of signal transduction pathways, and pathology. Exp Cell Res. 2008; 314(9):1951-1961.
92. Morrison LD, Cao XC and Kish SJ. Ornithine decarboxylase in human brain: influence of aging, regional distribution, and Alzheimer's disease. J Neurochem. 1998; 71(1):288-294.
93. Nilsson JA, Keller UB, Baudino TA, Yang C, Norton S, Old JA, Nilsson LM, Neale G, Kramer DL, Porter CW and Cleveland JL. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation. Cancer Cell. 2005; 7(5):433-444.
94. Deng W, Jiang X, Mei Y, Sun J, Ma R, Liu X, Sun H, Tian H and Sun X. Role of ornithine decarboxylase in breast cancer. Acta biochimica et biophysica Sinica. 2008; 40(3):235-243.
95. McElwee JJ, Schuster E, Blanc E, Thornton J and Gems D. Diapause-associated metabolic traits reiterated in long-lived daf-2 mutants in the nematode Caenorhabditis elegans. Mech Ageing Dev. 2006; 127(5):458-472.
96. Vanfleteren JR and De Vreese A. The gerontogenes age-1 and daf-2 determine metabolic rate potential in aging Caenorhabditis elegans. FASEB J. 1995; 9(13):1355-1361.
97. Willems L, Garnham B and Headrick JP. Aging-related changes in myocardial purine metabolism and ischemic tolerance. Exp Gerontol. 2003; 38(10):1169-1177.
98. Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV and Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY). 2010; 2(6):344-352.
99. Leontieva OV and Blagosklonny MV. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Aging (Albany NY). 2010; 2(12):924-935.
100. Moskalev A, Plyusnina E, Shaposhnikov M, Shilova L, Kazachenok A and Zhavoronkov A. The role of D-GADD45 in oxidative, thermal and genotoxic stress resistance. Cell Cycle. 2012; 11(22):4222-4241.
101. Plyusnina EN, Shaposhnikov MV and Moskalev AA. Increase of Drosophila melanogaster lifespan due to D-GADD45 overexpression in the nervous system. Biogerontology. 2011; 12(3):211-226.
102. Chen X, Liu G, Zhu J, Jiang J, Nozell S and Willis A. Isolation and characterization of fourteen novel putative and nine known target genes of the p53 family. Cancer Biol Ther. 2003; 2(1):55-62.
103. Rattan SI. Hormetic modulation of aging and longevity by mild heat stress. Dose Response. 2005; 3(4):533-546.
104. Moskalev A. Radiation-induced life span alteration of Drosophila lines with genotype differences. Biogerontology. 2007; 8(5):499-504.
105. Moskalev AA, Plyusnina EN and Shaposhnikov MV. Radiation hormesis and radioadaptive response in Drosophila melanogaster flies with different genetic backgrounds: the role of cellular stress-resistance mechanisms. Biogerontology. 2011; 12(3):253-263.
106. Moskalev A, Shaposhnikov M and Turysheva E. Life span alteration after irradiation in Drosophila melanogaster strains with mutations of Hsf and Hsps. Biogerontology. 2009; 10(1):3-11.
107. Blagosklonny MV. Hormesis does not make sense except in the light of TOR-driven aging. Aging (Albany NY). 2011; 3(11):1051-1062.
108. Yip CK, Murata K, Walz T, Sabatini DM and Kang SA. Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition. Mol Cell. 2010; 38(5):768-774.
109. Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham R, Ashendel C, Zalkow L, Matter WF, Dodge J, Grindey G and et al. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 1994; 54(9):2419-2423.
110. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ and Knowles RG. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem. 1997; 272(8):4959-4963.
111. Kaplan EL and Meier P. (1992). Nonparametric Estimation from Incomplete Observations. In: Kotz S and Johnson N, eds. Breakthroughs in Statistics: Springer New York), pp. 319-337.
112. Fleming TR, O'Fallon JR, O'Brien PC and Harrington DP. Modified Kolmogorov-Smirnov test procedures with application to arbitrarily right-censored data. Biometrics. 1980; 36(4):607-625.
113. Breslow N. A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika. 1970; 57(3):579-594.
114. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966; 50(3):163-170.
115. Wang C, Li Q, Redden DT, Weindruch R and Allison DB. Statistical methods for testing effects on "maximum lifespan". Mech Ageing Dev. 2004; 125(9):629-632.
116. Bonilla-Ramirez L, Jimenez-Del-Rio M and Velez-Pardo C. Low doses of paraquat and polyphenols prolong life span and locomotor activity in knock-down parkin Drosophila melanogaster exposed to oxidative stress stimuli: implication in autosomal recessive juvenile Parkinsonism. Gene. 2013; 512(2):355-363.
117. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B and Overington JP. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2012; 40(Database issue):D1100-1107.
118. Kanehisa M and Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000; 28(1):27-30.
119. Joshi-Tope G, Gillespie M, Vastrik I, D'Eustachio P, Schmidt E, de Bono B, Jassal B, Gopinath GR, Wu GR, Matthews L, Lewis S, Birney E and Stein L. Reactome: a knowledgebase of biological pathways. Nucleic Acids Res. 2005; 33(Database issue):D428-432.
120. Du P, Feng G, Flatow J, Song J, Holko M, Kibbe WA and Lin SM. From disease ontology to disease-ontology lite: statistical methods to adapt a general-purpose ontology for the test of gene-ontology associations. Bioinformatics. 2009; 25(12):i63-68.
121. Gene Ontology Consortium. Gene Ontology annotations and resources. Nucleic Acids Res. 2013; 41(Database issue):D530-535.
122. Durinck S, Moreau Y, Kasprzyk A, Davis S, De Moor B, Brazma A and Huber W. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics. 2005; 21(16):3439-3440.
123. Durinck S, Spellman PT, Birney E and Huber W. Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nature protocols. 2009; 4(8):1184-1191.
124. Feng G, Shaw P, Rosen ST, Lin SM and Kibbe WA. Using the bioconductor GeneAnswers package to interpret gene lists. Methods Mol Biol. 2012; 802:101-112.